Circle Pharma, Inc., a biopharmaceutical company advancing the discovery and development of intrinsically cell-permeable macrocycles, appointed Michael Cox, senior vice president, head of early development, and Edward Garmey, consulting chief medical officer. The additions to the leadership team further bolster Circle Pharma’s capabilities in oncology drug development as it advances its Cyclin A/B inhibitor program into clinical studies. Cox will play a crucial role in driving the compa...